Issue 2: The Deceptive Rx Ballot Issue
Ohioans need access to affordable medications. But Issue 2 won’t fix the problem. In fact, it’ll make things worse.
Read the fine print: Issue 2 lacks detail and information regarding how it would actually be implemented, and as a result, will lead to more bureaucratic red tape, delays, lawsuits and higher costs for taxpayers.
Here’s the problem: Issue 2’s main funder is a controversial California health care CEO whose billion-dollar-a-year organization makes 80 percent of its money selling prescription drugs. And now his “plan” for Ohio threatens to drive up drug costs and limit access to medicine for seven million Ohioans—two thirds of the population—such as those who rely on Medicare, private insurance or employer-based insurance. For more facts, review these FAQs.
The Columbus Dispatch agrees that Issue 2 “carries dire side effects” and that the “simplistic ballot issue could hike costs, reduce Ohioans’ choices.” And Akron Beacon Journal reports that Issue 2 “features too many flaws in its structure” to work.
Equipped with the truth on Issue 2, Ohioans from all walks of life, including more than 70 Ohio organizations, are uniting against it.